Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Columbus – Presentation of Q3 2024 interim report

Af Kasper LihnHead of Research
Columbus

Columbus expects to announce its Q3 2024 report on 5 November 2024. On 7 November 2024 at 15:00, Columbus’ CEO & President Søren Krogh Knudsen and CFO Brian Iversen will present the results and answer questions from the audience in an online live event.

Looking back at the recent quarter, Columbus grew revenue by 9% (8% growth adjusted for acquisitions and currency), and the EBITDA margin was 7.0% in Q2 2024. To achieve the company’s goal of 15% EBITDA margin by the end of 2026, Columbus has streamlined its organization in Q2 2024 with full effect in Q4 2024. The full-year 2024 financial guidance was maintained, implying an organic revenue growth in the range of 8-10% and an EBITDA margin in the range of 9-10%.

Columbus is a Danish-listed global IT services and consulting company, specializing in digital transformation with a main focus in the manufacturing, retail & distribution, food & beverage, and life science industries. Headquartered in Denmark and with offices and partners across many parts of the world, Columbus advises, implements, and manages IT solutions within areas such as Cloud ERP, Digital Commerce, Data & AI, Customer Experience & Engagement, and Security. The Columbus share is listed on Nasdaq Copenhagen (Ticker: COLUM).

Disclaimer: HC Andersen Capital receives payment from Columbus for a Digital IR/Corporate Visibility subscription agreement. /Kasper Lihn, 14 October 2024 at 8.57 AM.

Cinclus Pharma, Audiocast, Q1'25
20.05.2025, 10.00 Cinclus Pharma
Lagercrantz Group, Audiocast with teleconference, Q4'24/25
20.05.2025, 10.00 Lagercrantz Group
Relais as an Investment | Investor Day May, 19, 2025
19.05.2025, 15.00 Relais Group
Endomines as an Investment | Investor Day May 19, 2025
19.05.2025, 15.00 Endomines Finland
Scandinavian Medical Solutions - Præsentation af H1 2024/25
19.05.2025, 13.00 Scandinavian Medical Solutions
Vis alle videoer
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.